BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30257902)

  • 1. Coccidioidomycosis Complement Fixation Titer Trends in the Age of Antifungals.
    McHardy IH; Dinh BN; Waldman S; Stewart E; Bays D; Pappagianis D; Thompson GR
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
    Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
    Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary coccidioidomycosis.
    Thompson GR
    Semin Respir Crit Care Med; 2011 Dec; 32(6):754-63. PubMed ID: 22167403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coccidioidomycosis.
    Bays DJ; Thompson GR
    Infect Dis Clin North Am; 2021 Jun; 35(2):453-469. PubMed ID: 34016286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies.
    Crum NF; Lederman ER; Stafford CM; Parrish JS; Wallace MR
    Medicine (Baltimore); 2004 May; 83(3):149-175. PubMed ID: 15118543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coccidioidomycosis: Experience From a Children's Hospital in an Area of Endemicity.
    Dimitrova D; Ross L
    J Pediatric Infect Dis Soc; 2016 Mar; 5(1):89-92. PubMed ID: 26908496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coccidioidomycosis (Valley Fever) in Primary Care.
    Herrick KR; Trondle ME; Febles TT
    Am Fam Physician; 2020 Feb; 101(4):221-228. PubMed ID: 32053327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of coccidioidin and spherulin in complement fixation tests for coccidioidomycosis.
    Huppert M; Krasnow I; Vukovich KR; Sun SH; Rice EH; Kutner LJ
    J Clin Microbiol; 1977 Jul; 6(1):33-41. PubMed ID: 886007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis.
    Thompson GR; Lunetta JM; Johnson SM; Taylor S; Bays D; Cohen SH; Pappagianis D
    Clin Infect Dis; 2011 Sep; 53(6):e20-4. PubMed ID: 21865185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent pulmonary infection with an azole-resistant Coccidioides species.
    Kriesel JD; Sutton DA; Schulman S; Fothergill AW; Rinaldi MG
    Med Mycol; 2008 Sep; 46(6):607-10. PubMed ID: 18608910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coccidioidomycosis: Recent Updates.
    Twarog M; Thompson GR
    Semin Respir Crit Care Med; 2015 Oct; 36(5):746-55. PubMed ID: 26398540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coccidioidomycosis: evaluation of parameters used to predict outcome with amphotericin B therapy.
    Hardenbrook MH; Barriere SL
    Mycopathologia; 1982 May; 78(2):65-71. PubMed ID: 7099244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating opportunistic infections: coccidioidomycosis.
    Ampel NM
    Expert Opin Pharmacother; 2004 Feb; 5(2):255-61. PubMed ID: 14996623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid antibodies detected by ELISA against a 33-kDa antigen from spherules of Coccidioides immitis in patients with coccidioidal meningitis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Galgiani JN; Peng T; Lewis ML; Cloud GA; Pappagianis D
    J Infect Dis; 1996 Feb; 173(2):499-502. PubMed ID: 8568322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric coccidioidomycosis in central California: a retrospective case series.
    McCarty JM; Demetral LC; Dabrowski L; Kahal AK; Bowser AM; Hahn JE
    Clin Infect Dis; 2013 Jun; 56(11):1579-85. PubMed ID: 23463637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seronegative disseminated coccidioidomycosis in patients with HIV infection.
    Antoniskis D; Larsen RA; Akil B; Rarick MU; Leedom JM
    AIDS; 1990 Jul; 4(7):691-3. PubMed ID: 2397064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
    Catanzaro A; Cloud GA; Stevens DA; Levine BE; Williams PL; Johnson RH; Rendon A; Mirels LF; Lutz JE; Holloway M; Galgiani JN
    Clin Infect Dis; 2007 Sep; 45(5):562-8. PubMed ID: 17682989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes among inmates treated for coccidioidomycosis at a correctional institution during a community outbreak, Kern County, California, 2004.
    Burwell LA; Park BJ; Wannemuehler KA; Kendig N; Pelton J; Chaput E; Jinadu BA; Emery K; Chavez G; Fridkin SK
    Clin Infect Dis; 2009 Dec; 49(11):e113-9. PubMed ID: 19886797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment considerations in pulmonary coccidioidomycosis.
    Hartmann CA; Aye WT; Blair JE
    Expert Rev Respir Med; 2016 Oct; 10(10):1079-91. PubMed ID: 27635942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis.
    Ampel NM; Giblin A; Mourani JP; Galgiani JN
    Clin Infect Dis; 2009 Jan; 48(2):172-8. PubMed ID: 19072555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.